#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiectasis Drug eruption Squamous cell carcinoma of the cervix Glioblastoma multiforme Dermatitis Trigeminal neuralgia Crohn's disease Microscopic polyangiitis Angiosarcoma Neuromyelitis optica spectrum disorder Usher's syndrome Hereditary neuropathic amyloidosis Chronic myeloid leukaemia Neuroendocrine carcinoma metastatic Immunodeficiency common variable More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Life with Disease Alexander disease – Basic Information Proteus syndrome – Trials in Disease Myelodysplastic syndrome with excess blasts – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Basic Information Idiopathic inflammatory myopathy – Treatment Von Willebrand’s disease – Life with Disease Factor VIII deficiency – Trials in Disease Amyotrophic lateral sclerosis – Life with Disease Pemphigus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avibactam Chlorhexidine Dihydrochloride Vb10.16 Tinlarebant GSKVX000000048111 GSK5784283 SODIUM BENZOATE Rondaptivon Pegol Doxecitine Oxazepam Tamibarotene Allopurinol Sodium Etrinabdione Valoctocogene Roxaparvovec Canagliflozin Tolebrutinib Cabotegravir Tadekinig Alfa Anhydrous Docetaxel Acoramidis Hydrochloride More therapies…

    Learn about Your Condition

    Portal hypertension Endometrial cancer stage III Oral neoplasm Urea cycle disorder Vasospasm Niemann-Pick disease T-cell type acute leukaemia Peptostreptococcus infection Perthes disease Colon cancer metastatic Kaposi's sarcoma Sarcoma Lennox-Gastaut syndrome Follicular lymphoma stage IV Cutaneous lupus erythematosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    • Primary progressive multiple sclerosis
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Fludarabine Phosphate
    • Cyclophosphamide
    France Germany Italy Spain

  • Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • ALE.P02
    • Pembrolizumab
    France Italy Spain

  • Study on the Effects of Tirzepatide on Reducing Alcohol Intake in Patients with Schizophrenia and Alcohol Use Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    • Schizophrenia
    Investigated Drugs:
    • Sodium Chloride
    • Tirzepatide
    Denmark

  • Study on Nivolumab and MesoPher for Patients with Peritoneal Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
    • Nivolumab
    The Netherlands

  • Long-term Follow-up Study for Patients with Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Treated with OC-1 Cells

    Recruiting

    3 1 1
    Investigated Drugs:
    • Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
    Spain

  • Study on Vedolizumab and Ustekinumab for Patients with Crohn’s Disease and Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Ustekinumab
    Denmark
Previous Page
1 … 229 230 231 232 233 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!